LCID
Lucid Group, Inc.
LCID has a slight edge over LZB overall, supported by stronger fundamentals and stronger valuation.
LZB
La-Z-Boy Incorporated
LZB has lower modeled downside risk, despite its lower overall score.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
LZB Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Stable | |
| Strong |
LZB's balance sheet is currently strong, and its revenue, profitability and cash flow are stable.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
LZB PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 8.8x | $17.26 | -47% |
| Forward | 13x | $32.53 | — |
| Fair | 14x | $28.41 | -13% |
| Current | 17x | $32.53 | — |
| Expensive | 18x | $36.00 | +11% |
Historical ranges are pointers, not guarantees.
LZB's PE is in its expensive range at 17x. If earnings grow as analysts expect, today's price would be 13x next year's earnings, in its cheap range.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
LZB Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Stable | |
| Improving | |
| Limited | |
| High |
Analysts expect LZB's earnings to grow and its profitability to improve, with its revenue holding steady.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID is still losing money, but less than at its worst: $13.08 per share over the past year, against $16.50 at its worst in mid-2023.
LZB Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.59 | +32% |
| Q3 2026 | $1.97 | -9.6% |
| Q2 2026 | $2.47 | +5.1% |
| Q1 2026 | $2.01 | -31% |
| Q4 2025 | $2.17 | -25% |
| Q3 2025 | $2.18 | -22% |
| Q2 2025 | $2.35 | -17% |
| Q1 2025 | $2.91 | +7.8% |
| Q4 2024 | $2.89 | +4% |
LZB has the edge over LCID on earnings quality, reporting a profit while its opponent remains loss making.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID has the edge over LZB on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID's operating margin was −245% last quarter, up 35 points from the same quarter a year ago, near the top of its range since 2020.
LZB Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $475.7M | -3.4% |
| Q2 2026 | $570.3M | -0.1% |
| Q1 2026 | $541.6M | +3.8% |
| Q4 2025 | $522.5M | +0.3% |
| Q3 2025 | $492.2M | -0.7% |
| Q2 2025 | $570.9M | +3.1% |
| Q1 2025 | $521.8M | +4.3% |
| Q4 2024 | $521M | +1.9% |
LZB's revenue fell from its 2022 peak and has held roughly level since: $476M last quarter, down 3.4% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -0.4% | -4.9 points |
| Q2 2026 | 7.2% | +2.1 points |
| Q1 2026 | 5.5% | -1.2 points |
| Q4 2025 | 6.9% | -0.5 points |
| Q3 2025 | 4.5% | -2.1 points |
| Q2 2025 | 5.2% | -3.9 points |
| Q1 2025 | 6.7% | +0.2 points |
| Q4 2024 | 7.4% | +0.9 points |
LZB has the edge over LCID on profitability, with a higher operating margin.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has burned cash in almost every quarter: −$5.2B over the past year, against −$3.4B the year before.
LZB Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$7.6M | -143% |
| Q2 2026 | $8.8M | -77% |
| Q1 2026 | $71.6M | +87% |
| Q4 2025 | $29.6M | +$30.8M |
| Q3 2025 | $17.8M | -51% |
| Q2 2025 | $39.3M | +5.4% |
| Q1 2025 | $38.2M | +3.5% |
| Q4 2024 | -$1.2M | -107% |
LZB has the edge over LCID on cash generation, producing positive trailing cash flow while its opponent burns cash.
LCID Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.3% | +12.5M shares |
| 1 year | +26% | +82.4M shares |
| 3 years | +73% | +166M shares |
LCID has 395M diluted shares, up 26% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | $2.2M |
| Q1 2020 | — |
LZB Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -3.3% | -1.3M shares |
| 1 year | -3.5% | -1.4M shares |
| 3 years | -7.7% | -3.3M shares |
| 5 years | -12% | -5.4M shares |
| Available history | -15% | -6.9M shares |
LZB has the edge over LCID on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $25.1M |
| Q2 2026 | $20.2M |
| Q1 2026 | $13.7M |
| Q4 2025 | $809,000 |
| Q3 2025 | $12.5M |
| Q2 2025 | $13.5M |
| Q1 2025 | $11.2M |
| Q4 2024 | $19.5M |
LZB spent $60M buying back its own shares over the past year, up 5.5% from the year before.
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
LZB Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.7x | Net Cash |
| Q2 2026 | -1.7x | Net Cash |
| Q1 2026 | -1.9x | Net Cash |
| Q4 2025 | -2.0x | Net Cash |
| Q3 2025 | -1.9x | Net Cash |
| Q2 2025 | -1.8x | Net Cash |
| Q1 2025 | -1.6x | Net Cash |
| Q4 2024 | -1.5x | Net Cash |
LZB has more cash than debt.
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
LZB Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 45.9 | Neutral |
| Stochastic | 22.6 | Neutral |
LZB's weekly RSI is 46 (neutral) and its Stochastic is 23 (neutral).
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
LZB PE vs Consumer Cyclical Sector
| Metric | LZB | Sector median | Relative |
|---|---|---|---|
| PE | 17x | 18x | 8.4% below |
| PE % | 71 | 47 | 24 pts above |
LZB is trading at 17x earnings, in line with the Consumer Cyclical sector's median of 18x.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
LZB Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $30.5 | 6.8% above |
| 20 week MA | $34.3 | 5.1% below |
| 50 week MA | $35.7 | 8.9% below |
| 100 week MA | $37.3 | 13% below |
| 200 week MA | $35.9 | 9.3% below |
LZB has the edge over LCID on trend strength, trading above more of its moving averages.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has finished four years in a row lower, and it's down 72% so far in 2026.
LZB Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $31.5 | $41.2 | +31% |
| 2021 | $41.2 | $36.1 | -12% |
| 2022 | $36.1 | $23.5 | -35% |
| 2023 | $23.5 | $36.9 | +57% |
| 2024 | $36.9 | $43.3 | +17% |
| 2025 | $43.3 | $37.8 | -13% |
| 2026 YTD | $37.8 | $32.5 | -14% |
LZB has the edge over LCID on returns for 2026, with the stronger performance.